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Abstract
Background: The mechanisms underlying the pathogenesis of cerebral malaria (CM) syndrome are not well
understood. Previous studies have shown a strong association of inflammatory chemokines, apoptotic markers and
angiogenic molecules with CM associated mortality. Recognizing the importance of angiopoietins (ANG) in the
pathogenesis of CM, a retrospective investigation was carried out in a hospital cohort of malaria patients with
Plasmodium infection in central India to determine if these factors could be suitable markers of CM associated
severity.
Methods: Patients enrolled in the study were clinically characterized as healthy controls (HC), mild malaria (MM),
CM survivors (CMS) and CM non-survivors (CMNS) based on their malaria status and hospital treatment outcome.
Plasma ANG-1 and ANG-2 levels were assessed using sandwich ELISA. Receiver operating characteristic (ROC) curve
analysis was used to calculate area under the curve (AUC) for each biomarker in order to assess predictive accuracy
of individual biomarkers.
Results: The plasma levels of ANG-1 were lower in CMS and CMNS compared to control groups (mild malaria and
healthy controls) at the time of hospital admission. On the contrary, ANG-2 levels positively correlated with malaria
severity and were significantly higher in CMNS. The ratio of ANG-2/ANG-1 was highest in CMNS compared to other
groups. Receiver operating characteristic curves revealed that compared to ANG-1 (AUC = 0.35), ANG-2 (AUC =
0.95) and ratio of ANG-2/ANG-1 (AUC = 0.90) were better markers to discriminate CMNS from MM cases. However,
they were less specific in predicting fatal outcome amongst CM cases at the time of hospital admission.
Conclusion: These results suggest that at the time of admission plasma levels of ANG-2 and ratio of ANG-2/ANG-1
are clinically informative biomarkers to predict fatal CM from MM cases while they have limited usefulness in
discriminating fatal CM outcomes in a pool of CM cases in endemic settings of Central India.
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Background
Cerebral malaria (CM) is a severe form of central ner-
vous system (CNS) pathology associated with Plasmo-
dium falciparum infection. It is characterized by
unarousable coma that often begins with seizures
among children but coma in adults is less frequently
associated with seizures [1]. Despite treatment, mortality
due to CM can be as high as 30%, while neurological
sequelae that are uncommon in adults occurred among
10% of children recovering from CM [1-3]. Further CM
is also associated with cognitive deficit [4,5]. Early diag-
nosis and prompt treatment can minimize or avert mor-
tality and morbidity associated with CM. The
mechanisms underlying the pathogenesis of this multi-
factorial syndrome are unclear.
Sequestration of parasitized red blood cells (PRBCs),
mainly late trophozoite and schizonts, within the micro-
vasculature (capillaries and post capillary venules) are
thought to play an important role in the pathogenesis of
CM [6]. It has also been proposed that downstream
events following sequestration, such as dysregulation of
the immune system (primarily by over-production of
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IFN-g and its inducible protein CXCL10/IP-10) may
play an important role in the pathogenesis [7-10]. Para-
site-induced soluble factors may contribute directly to a
breach in the blood brain barrier (BBB) and neuronal
pathology, possibly via apoptotic pathways [11].
Platelets (regulators of haemostasis) have also been
considered as effectors of CM pathogenesis. Binding of
platelets and platelet microparticles (PMP) (facilitated
on one hand by sticky von-Willebrand factor [vWF]
exposed on activated endothelium and on another with
PRBCs through receptors CD-31 and CD-36) may pro-
mote cytotoxicity to the TNF and LT-a activated brain
endothelial cells (EC) [12,13]. As evidenced from these
studies, the acute and advanced phases of CM are
thought to be associated with endothelial sequestration,
inflammation and hemostatic disorder leading to micro-
circulatory dysfunction [14].
Previous studies carried out among Indian CM
patients have shown that severe malaria patients who
died of CM had significantly lower plasma levels of
angiogenic factors such as vascular endothelial growth
factor (VEGF) and platelet derived growth factor
(PDGFbb) [10,15]. Other angiogenic factors such as
angiopoietins (ANG) have recently been investigated
among African children and South East Asian adults to
test their utility as potential functional biomarkers for
severe malaria [15].
ANG-1 is a vascular quiescence molecule whereas
ANG-2 is an antagonist of ANG-1 by binding to the
common receptor Tie-2 [16]. ANG-2 primes the
endothelium to respond to exogenous stimuli and facili-
tates the activities of inflammatory factors (TNF and IL-
1) and angiogenic factors like VEGF and PDGFbb [17].
Recent studies have reported different levels of specifi-
city and sensitivity in using ANG-1, ANG-2 and ANG-
1/ANG-2 ratio for discriminating CM patients from
other malaria patients [18-21].
VEGF is an important factor that induces angiogenesis
and vasculogenesis. Interactions of angiopoietins with
VEGF promote angiogenesis, whereas in the absence of
VEGF, ANG-2 causes regression of blood vessels [16].
To better understand the role of ANG-1 and ANG-2 in
CM outcomes in a different malaria endemic setting, a
retrospective investigation was carried out in Central
India. In addition, predictive values of ANG-1, ANG-2
and their ratios were also determined in order to test
the utility of these factors in discriminating fatal CM
from non-fatal CM and mild malaria patients.
Methods
Study background and site
Samples used in this study were collected as part of an
NIH-funded research project (R21TW006804-01) from
2004 to 2007 at NSCB Medical College Hospital, Jabal-
pur and Civil Hospital Maihar, district Satna, both in
the state of Madhya Pradesh, Central India. This study
was approved by the ethical research committee of
National Institute of Malaria Research New Delhi,
Regional Medical Research Center for Tribals, Jabalpur,
Center for Disease Control and Prevention, CDC,
Atlanta, GA and Morehouse School of Medicine,
Atlanta, GA, USA.
Subjects and enrolment criteria
Children (< = 14 years) and adults with only P. falci-
parum positive asexual stage parasitaemia on blood
smear were enrolled after obtaining written informed
consent from their parents or close relatives. Consent
was also obtained for long-term storage and later use of
samples. Patients satisfying the enrolment criteria were
enrolled as healthy control (HC), mild malaria (MM)
and cerebral malaria (CM) following the definition given
below. Malaria associated complications were defined
using WHO criteria [1,22].
Healthy control
Relatives of patients in the hospital and members of the
community who did not have malaria or other febrile
illness 60 days before enrollment, and no past history of
mental/metabolic illness, tuberculosis, meningitis, or
accidental head injury were included.
Mild malaria
Patients who had fever with P. falciparum parasitaemia
of < 25,000 parasites/μl of blood (detected microscopi-
cally from blood smears) and no evidence of severe
malaria and no past history of mental/metabolic illness,
tuberculosis, meningitis, or accidental head injury were
included.
Cerebral malaria
To be considered a case of CM, a patient had to fulfill
the WHO’s definition of severe CM [1], have a Glasgow
coma score of ≤ 10 [23] have a P. falciparum parasitae-
mia, and have no other clinically evident cause of
impaired consciousness, no past history of mental/meta-
bolic illness, tuberculosis, meningitis, or accidental head
injury were included.
Blood samples
Venous blood samples were obtained prior to treatment
with intravenous quinine or a-b arteether. On the basis
of treatment outcome, CM patients were further divided
into two subgroups; CM survivors (CMS) and CM non-
survivors (CMNS). Detailed description of patients has
been described elsewhere [22].
Detection of ANG-1 and ANG-2 levels
Plasma ANG-1 and ANG-2 levels were assessed by
sandwich ELISA (R & D Systems, Minneapolis, MN)
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maxisorb, ELISA plates were incubated overnight with
100 μl of diluted capture antibody for ANG-1/ANG-2 in
PBS (pH = 7.2). This was followed by three washes with
buffer (PBS pH 7.2 and 0.05% Tween 20). Blocking was
done by 1% bovine serum albumin in PBS for 1 h.
Recombinant proteins were serially diluted as recom-
mended, to obtain a seven point standard curve. All the
samples were diluted 1:4 in reagent diluent. Samples
that showed higher OD than the highest standard were
diluted further. Samples and standards were incubated
for 1 h at room temperature (on shaker at 500 rpm),
followed by washing and addition of detection antibo-
dies, which were incubated for 1 h. After four washes,
streptavidin-HRP was addeda n di n c u b a t e df o r2 0m i n .
The substrate tetra methyl benzidine (TMB)/H2O2
(Bangalore, Genie, India) was added and plates were
incubated at room temperature in the dark for 20 min.
Fifty microlitres of stop solution (2N H2SO4) were then
added to each well and optical density (OD) was
assessed at 450 nm.
Sensitivity of immunoassay
Upper and lower limits of detection for each biomarker
were: ANG-1, 10000 - 156.25 pg/mL and for ANG-2,
3500 - 54.69 pg/mL (according to manufacturer). Detec-
tion in our samples (diluted 1:4) ranged from 7527.6-
71.9 pg/mL for ANG-1 and 3500-11.6 pg/mL for ANG-
2.
Statistical analysis
Statistical analyses were performed using STATA ver-
sion 8.2 software (StataCorp, College Station, TX).
Receiver operating characteristic (ROC) curve and area
under the ROC curves (AUC) were generated. Continu-
ous variables were analysed using the Kruskal-Wallis
test. Angiopoietin levels and survival outcomes were
analysed using the Wilcoxon rank-sum test. Categorical
variables were analysed using Chi-square test. P value <
0.05 was considered significant. Cut-off values were
derived mathematically from the ROC curves, using the
ROC curve with the lowest value for the formula: (1-
sensitivity)
2 + (1-specificity)
2. Logistic regression analysis
was done in order to strictly define association of cate-
gorical severity indicators with mortality controlling for
age and parasitaemia.
Results
Clinical characteristics of study subjects
The details of patients’ characteristics and clinical para-
meters are given in Table 1. There were no significant
differences between the patients’ age, parasitaemia and
gender (P > 0.05). The study population was comprised
of both adults and children, wherein the Glasgow coma
score for CMNS was significantly lower (P < 0.015) than
CMS. Respiratory distress (P < 0.045) and seizure (P =
0.061) were found to be associated with CMNS than
CMS. However, in multivariate logistic regression analy-
sis (controlling for age and parasitemia) respiratory dis-
tress and seizure were not associated with mortality
outcome in CM (P = 0.062 and 0.088 respectively). As
expected, HC had significantly higher haemoglobin
levels than MM (P < 0.002), CMS (< 0.0001) and CMNS
(P < 0.0001). Plasma levels of angiopoietins were not
affected by age, gender and parasitaemia in this study (P
> 0.05). Among CM patients, respiratory complication,
seizures and severe anaemia were not associated with a
rise in plasma angiopoietins (P > 0.05).
ANG-1, ANG-2 and their ratios versus disease severity
Plasma levels of ANG-1 and ANG-2 among the 183
subjects were assessed. Plasma levels of ANG-1 declined
with disease severity (Figure 1). Compared to HC, med-
ian plasma levels of ANG-1 significantly declined (2.7
fold) among MM subjects (P < 0.0001), 4.4 fold in CMS
(P < 0.0001), and 5.3 fold in CMNS (P < 0.0001). As
compared to MM, there was a 1.6-fold and 2-fold
decline in ANG-1 levels in CMS (P < 0.0035) and
CMNS groups (P < 0.025), respectively. However, ANG-
1 levels were not significantly different between CMNS
and CMS (P = 0.8). In contrast, the median plasma
levels of ANG-2 progressively increased with disease
severity (Figure 1). Compared to HC group, a 2.9-fold
increase was observed in MM group (P < 0.0001), 11.3
fold in CMS (P < 0.0001) and 23.2 fold in CMNS (P <
0.0001). In comparison to MM, CMS and CMNS
showed 3.9- (P < 0.0001) and 8-fold (P < 0.0001)
increase, respectively. The median ANG-2 levels were
significantly higher (2 fold) among CMNS than CMS (P
< 0.0001).
The median ratios of ANG-2/ANG-1 progressively
increased with disease severity (Table 1). Compared to
HC group, an increase of 8 fold was observed in MM
group (P < 0.0001), 71-fold increase in CMS (P <
0.0001) and 134.5-fold increase in CMNS (P < 0.0001)
group. In comparison with MM, CMS and CMNS
showed 8.8-fold (P < 0.0001) and 16.8-fold (P < 0.0001)
increases, respectively. The median ratio was signifi-
cantly higher (1.9 fold) among CMNS than CMS (P <
0.001).
Receiver operating characteristics (ROC) curves
Biomarkers that predict development of severe malaria
outcome can be clinically utilized for prognosis, diagno-
sis and disease management. An additional analysis of
data using ROC curves was undertaken to determine
the cutoff value that discriminates between two groups
with reasonable sensitivity and specificity. ROC curves
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Page 3 of 7Table 1 Clinical/parasitological characteristics and angiopoietins level of enrolled patients (HC = healthy controls, MM
= mild malaria, CMS = cerebral malaria survivors and CMNS = cerebral malaria non survivors)
Variable HC MM CMS CMNS
Number 34 57 63 29
Age (IQR) 25 (14-32) 19 (12-36) 25 (12-40) 25 (13.5-37.5)
Children, n (%) 9 (26.4) 20 (35.1) 21 (33.3) 8 (27.6)
Gender (M/F) 23/11 29/28 44/19 18/11









Seizure (%) 0 0 20 (31.74) 15 (51.72)
Hypoglycaemia, n (%) 0 0 4 (6.34) 1 (3.44)
Renal failure, n (%) 0 0 15 (23.80) 8 (27.58)
Jaundice, n (%) 0 0 13 (20.63) 6 (20.68)
Hepatic Encephalopathy,
n (%)
0 0 4 (6.34) 2 (6.89)
Respiratory failure, n (%) 0 0 10 (15.87) 10 (34.48)
Haemolysis, n (%) 0 0 7 (11.11) 1 (3.44)
Abnormal bleeding, n (%) 0 0 1 (1.58) 3 (10.34)
Hypotension, n (%) 0 0 11 (17.46) 7 (24.13)
Mild anaemia, n (%) 8 (23.5) 20 (35) 20 (31.74) 6 (20.68)
Moderate anaemia, n (%) 0 9 (15.7) 21 (33.33) 9 (31.03)
Severe anaemia, n (%) 0 2 (3.5) 7 (11.11) 6 (20.68)
















335.9 (163.9-599.2) 968.7 (480.3-1948.9) 3580.73 (1193.59-7104.86) 7779.06 (5701.50-12197.17)
ANG-2/ANG-1
(IQR)
0.02 (0.01-0.05) 0.16 (0.08-0.47) 1.42 (0.41-2.91) 2.69 (1.06-7.04)
Parasites/300 WBCs (IQR) 0 44 (21-128) 28 (7-237) 42 (8-296)
Continuous variables were presented as median inter quartile range (IQR) and categorical variables were presented as numbers (%), except gender. Groups were
compared using Kruskal-Wallis test (continuous variable) and Chi-square test (categorical variables)
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Figure 1 Angiopoietins (ANG) were assessed using ELISA. Plasma levels of ANG among studied groups (HC = healthy controls, MM = mild
malaria, CMS = cerebral malaria survivors and CMNS = cerebral malaria non-survivors) are presented with box plots (25-75 percentile distribution
of data) with bars and medians. Data shown as points are outliers.
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and CMNS versus CMS patients. The area under curve
(AUC) of ANG-1 for CMNS versus MM was 0.35 and
for CMNS versus CMS 0.50 (Figure 2a, d).
The AUC of ANG-2 was shown to be 0.95 for CMNS
versus MM and 0.76 for CMNS versus CMS (Figure 2b,
e). A cut-off value of 3246.8 pg/ml was 89.7% sensitive
and 89.5% specific in differentiating CMNS from MM
patients while a cut-off of 4924.52 pg/ml was 82.8% sen-
sitive and 63.5% specific in differentiating CMNS from
CMS. The ANG-2/ANG-1 ratio was shown to have
AUC of 0.90 for CMNS versus MM, and 0.69 for
CMNS versus CMS (Figure 2c, f). However, a cut-off
ratio of 0.69 was shown to be 86.2% sensitive and 83%
specific in differentiating CMNS from MM, and a cut-
off ratio at 1.58 was 65.5% sensitive and 60.3% specific
in differentiating CMNS from CMS.
Discussion
Early detection and prognosis of CM patients with a
higher risk for fatal outcome is necessary for better clin-
ical case management and improvement of treatment
outcome. It is anticipated that a better understanding of
mechanisms contributing to CM-associated death will
help in the development of novel adjunctive therapies to
reduce mortality associated with CM. Currently there is
no reliable biological test that can predict CM or its
associated complications, including mortality and post
recovery neurological deficits. This study reveals that in
Indian CM patients ANG-2 and ANG-2/ANG-1 ratios
had high levels of sensitivity and specificity (area under
the ROC curve close to 1) in discriminating CMNS
from MM patients. However, ANG-2 levels differen-
tiated CMNS from CMS with high sensitivity, but mod-
erate levels of specificity.
Other studies demonstrated ANG-1 as a good biomar-
ker in differentiating CM from MM among Thai adults,
but not in Ugandan children [24]. Yeo et al. reported that
ANG-2 is a better marker of severe malaria associated
deaths than lactate in Indonesian adults [15]. Among
Ugandan children higher levels of ANG-1 were found to
be associated with a reduced risk of death [24]. However,
in our study population ANG-1 levels were not good
prognostic indicators by themselves in as much as this
study observed a decrease in ANG-1 levels with disease
severity. Interestingly, in a recent study conducted with
Malawian children, ANG-1 levels were significantly down
regulated among CM patients with retinopathy compared
to those without retinopathy, uncomplicated malaria
patients and those with non-malarial encephalopathy
[18]. It is thought that differences in the epidemiology of
malaria between Asia and Africa, genetic differences in
these two distinct populations and other factors (e.g. age,
etc.) may explain these inconsistencies.
Consistent with earlier studies [15,18,20,21,24], this
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Figure 2 Assessment of angiopoietins (ANG) utility in discriminating between fatal malaria with other groups using ROC analysis.
Receiver operating characteristic curves (bold lines) were generated for each factor to compare CMNS with MM patients (a, b, c) or CMNS with
CMS (d, e, f). The null hypothesis (thin line) is that the area under the curve (AUC) equals 0.5. AUC for each curve is given just below the graphs.
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Page 5 of 7ANG-2 in the pathogenesis of CM in endemic setting of
Central India. The breach of blood brain barrier is
believed to be an important component in the patho-
genesis of CM [25,26] but a recent histologic study con-
ducted in Vietnamese adults who died of CM did not
support such a hypothesis [23]. In the Vietnamese
study, no significant correlation between vascular injury
and death associated with CM was evident [23]. Overall,
these findings suggest pathogenesis of CM is multifac-
torial and complex [28].
Platelets and PMP were described to enhance PRBCs
sequestration to EC and this is associated with accumu-
lation of host inflammatory cells [12,13]. Resultant
inflammation may lead to CM pathology which may
results in excess release of ANG-2 (from the Wiebel-
Palade bodies) and loosening of endothelial tight junc-
tions. vWF (mediate platelet/PRBCs sequestration) and
IL-8 which are co-packed with ANG-2 are also seen ele-
vated in severe malaria [12,24].
Also angiogenic expression of molecules are variable
among African CM children during acute and convales-
cence stages [18,20,27]. Interestingly platelet and infected
red blood cells which adhere to brain endothelial cells
and placenta during malarial pathology have recently
been reported to alter gene expression of EC and syncy-
tiotrophoblast respectively [29,30]. This in-turn may
result in EC apoptosis (via TNF, TGF-beta signaling) and
inhibition of angiogenesis in placental pathology (via
VEGF) [29,30]. Thus studies related to histopathology of
internal vital organs in addressing oedema and heamor-
rhages need to be done to better understand parasite-
dependent host’s pathogenic/protective pathways in CM.
Conclusions
Overall, the findings of this study suggest that plasma
l e v e l so fA N G - 2a n dr a t i oo fA N G - 2 / A N G - 1a ta d m i s -
sion are clinically informative biomarkers to predict fatal
CM from MM cases albeit limited usefulness in discri-
minating fatal CM outcomes in a pool of CM cases in
endemic settings of Central India. Combining the ANG-
2a n dr a t i oo fA N G - 2 / A N G - 1w i t ho t h e rs u i t a b l eb i o -
markers (such as IP-10, sICAM-1) can help to even-
tually develop suitable biomarker panels for predicting
CM associated fatal complications. The immunopatho-
genic role of ANG-2 with other important angiogenic
markers in systemic vital organ dysfunction needs to be
investigated in severe malaria. Further validation of
these findings in patient populations from different
endemic areas will help to eventually develop suitable
biomarkers for diagnostic and prognostic purposes.
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